Essential thrombocytosis epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 5: Line 5:


==Epidemiology==
==Epidemiology==
Essential thrombocytosis is diagnosed at a rate of about 2 to 3 per 100,000 individuals annually.<ref>{{cite journal | author = Mesa R, Silverstein M, Jacobsen S, Wollan P, Tefferi A | title = Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study, 1976-1995. | journal = Am J Hematol | volume = 61 | issue = 1 | pages = 10-5 | year = 1999 | id = PMID 10331505}}</ref><ref>{{cite journal | author = Kutti J, Ridell B | title = Epidemiology of the myeloproliferative disorders: essential thrombocythaemia, polycythaemia vera and idiopathic myelofibrosis. | journal = Pathol Biol (Paris) | volume = 49 | issue = 2 | pages = 164-6 | year = 2001 | id = PMID 11317963}}</ref> ET is a rare idiopathic condition affecting about 24 for every million people in the world<ref>Essential Thrombocythemia. Genetics Home Reference. http://ghr.nlm.nih.gov/condition/essential-thrombocythemia. Accessed on October 29, 2015</ref>.Although ET can present at any age, the disease usually affects middle aged to elderly individuals, with an average age at diagnosis being 50-70 years.<ref>Hoffman: Hematology: Basic Principles and Practice, 4th ed., 2005 Churchill Livingstone, Chapter 71.</ref>
ET is a rare idiopathic condition affecting about 24 for every million people in the world<ref>Essential Thrombocythemia. Genetics Home Reference. http://ghr.nlm.nih.gov/condition/essential-thrombocythemia. Accessed on October 29, 2015</ref>. Although ET can present at any age, the disease usually affects middle aged to elderly individuals, with an average age at diagnosis being 50-70 years.<ref>Hoffman: Hematology: Basic Principles and Practice, 4th ed., 2005 Churchill Livingstone, Chapter 71.</ref>


==References==
==References==

Revision as of 14:22, 29 October 2015

Essential thrombocytosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Epidemiology and Demographics

Risk Factors

Screening

Causes

Differentiating Essential thrombocytosis from other Diseases

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Essential thrombocytosis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Essential thrombocytosis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Essential thrombocytosis epidemiology and demographics

CDC on Essential thrombocytosis epidemiology and demographics

Essential thrombocytosis epidemiology and demographics in the news

Blogs on Essential thrombocytosis epidemiology and demographics

Directions to Hospitals Treating Essential thrombocytosis

Risk calculators and risk factors for Essential thrombocytosis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Epidemiology

ET is a rare idiopathic condition affecting about 24 for every million people in the world[1]. Although ET can present at any age, the disease usually affects middle aged to elderly individuals, with an average age at diagnosis being 50-70 years.[2]

References

  1. Essential Thrombocythemia. Genetics Home Reference. http://ghr.nlm.nih.gov/condition/essential-thrombocythemia. Accessed on October 29, 2015
  2. Hoffman: Hematology: Basic Principles and Practice, 4th ed., 2005 Churchill Livingstone, Chapter 71.


Template:WikiDoc Sources